Quick Answer
Anbio Biotechnology reported Stockholders Equity of $17.19 million for fiscal year 2024.
Anbio Biotechnology Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $17.19M | +16.0% |
| 2023 | $14.82M | +18.1% |
| 2022 | $12.55M | — |
- Anbio Biotechnology showed an increase of +16.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2024 period, Anbio Biotechnology’s stockholders equity has grown by 37.0% (from $12.55 million to $17.19 million).
- The most recent figure is from Anbio Biotechnology’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: